Cargando…
Optimal Treatments for Severe Malaria and the Threat Posed by Artemisinin Resistance
BACKGROUND: Standard treatment for severe malaria is with artesunate; patient survival in the 24 hours immediately posttreatment is the key objective. Clinical trials use clearance rates of circulating parasites as their clinical outcome, but the pathology of severe malaria is attributed primarily t...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452316/ https://www.ncbi.nlm.nih.gov/pubmed/30517708 http://dx.doi.org/10.1093/infdis/jiy649 |